Summary:
MacroPore Biosurgery is actively developing treatments for patients using regenerative cell technology. Our approach is unique in that we use adipose (fat) tissue as the source of regenerative cells. Regenerative cells from adipose tissue are of three primary kinds: adult stem cells, endothelial progenitor cells and growth factor producing cells. These cells have demonstrated in preclinical research that they have the ability to repair injured tissues.
Visit MacroPore Biosurgery.

Description (Web site quote):
Research applications include, peripheral vascular disease, cardiovascular tissue repair, bone regeneration, wound healing, and soft tissue augmentation. Our primary research focus is the repair of cardiovascular tissues that are damaged as a result of heart disease.

In 2003, we began development of a system to process autologous adipose (fat) tissue. This system could potentially allow physicians to isolate, concentrate and deliver regenerative cells at the point-of-care to treat a variety of medical conditions.
Visit MacroPore Biosurgery.